First Trust Advisors LP Tango Therapeutics, Inc. Transaction History
First Trust Advisors LP
- $108 Billion
- Q4 2024
Shares
2 transactions
Others Institutions Holding TNGX
# of Institutions
138Shares Held
91.1MCall Options Held
1.4KPut Options Held
4.4K-
Trv Gp Iv, LLC Boston, MA16.9MShares$29.7 Million64.97% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA10.7MShares$18.9 Million5.42% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA10.6MShares$18.7 Million1.53% of portfolio
-
Nextech Invest Ag5.53MShares$9.74 Million3.19% of portfolio
-
Farallon Capital Management LLC San Francisco, CA4MShares$7.04 Million0.07% of portfolio
About Tango Therapeutics, Inc.
- Ticker TNGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 88,067,296
- Market Cap $155M
- Description
- Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. Its lead program is TNG908, a synthetic lethal small molecule inhibitor of protein arginine methyltransferase 5 that is being developed as a treatment for cancers with methylthioadenosine phosphorylase deletions. The company also develops...